Research by SNS Insider values the global longevity market at USD 27.61 billion in 2025 and projects it will reach USD 67.03 billion by 2035, reflecting a 9.41% compound annual growth rate from 2026 to 2035.
The U.S. market is forecast to rise to USD 20.17 billion in 2035 from USD 9.16 billion in 2025, at an 8.34% CAGR. Growth is attributed to the rising prevalence of age-related illnesses, the wider uptake of preventive healthcare, the demand for nutraceuticals and anti-aging drugs, advances in regenerative medicine, and developments in AI-enabled drug discovery and biomarker technologies.
In 2025, nutraceuticals and dietary supplements held the largest product share at 28.05%, while senolytics and senotherapeutics are projected to record the fastest growth. Genomics and epigenetics led technology share in 2025, and biomarker or aging clock technologies are expected to expand rapidly.
Preventive healthcare and wellness represented the largest application segment, individuals accounted for the largest end-user share, and direct-to-consumer channels led distribution.
North America held the largest regional share in 2025, while the Asia Pacific is identified as the fastest-growing region. Major firms cited include Altos Labs, Calico Life Sciences and others.
